Overview Financials News + Filings
|
|
Curative Biotechnology Inc
|
|
| Operating Efficiency |
|
|
|
|
Annual |
|
| In millions, except per share items | Dec-31-21 | Dec-31-20 |
| | Source | Source |
| Turnover Ratios |
| Asset turnover | 2.6 | |
| |
| Returns on Capital |
| ROIC (excluding intangibles) | -376.3% | |
| ROIC (including intangibles) | -478.2% | -285.8% |
| ROE | -297.1% | -286.1% |
| ROA | -207.2% | -202.4% |
| |
| Cash Conversion Cycle |
| Days sales outstanding | 0.0 | 0.0 |
| Cash conversion cycle | 0.0 | 0.0 |
|